Influenza A, like Omicron SARS-CoV-2, Is Similarly Detected in Saliva or Nasopharyngeal Samples via RT-qPCR
Authors:
- Hellen AbreuHellen Abreu
- Carla Adriane RoyerCRCarla Adriane Royer
- Carolina Gracia PoitevinCPCarolina Gracia Poitevin
- Ana Flávia KohlerAKAna Flávia Kohler
- Ana Carolina RodriguesARAna Carolina Rodrigues
- Sonia Mara RaboniSRSonia Mara Raboni
- Meri Bordignon NogueiraMNMeri Bordignon Nogueira
- Pedro Henrique CardosoPCPedro Henrique Cardoso
- Monica Barcellos ArrudaMAMonica Barcellos Arruda
- Patrícia Alvarez da Silva BaptistaPBPatrícia Alvarez da Silva Baptista
- Ana Claudia BonattoABAna Claudia Bonatto
- Daniela Fiori GradiaDaniela Fiori Gradia
Open Access
Abstract
After the Coronavirus pandemic, the importance of virus surveillance was highlighted, reinforcing the constant necessity of discussing and updating the methods for collection and diagnoses, including for other respiratory viruses. Although the nasopharyngeal swab is the gold-standard sample for detecting and genotyping SARS-CoV-2 and Influenza viruses, its collection is uncomfortable and requires specialized teams, which can be costly. During the pandemic, non-invasive saliva samples proved to be a suitable alternative for SARS-CoV-2 diagnosis, but for Influenza virus the use of this sample source is not recognized yet. In addition, most SARS-CoV-2 comparisons were conducted before the Omicron variant emerged. Here, we aimed to compare Influenza A and Omicron RT-qPCR analysis of nasopharyngeal swabs and saliva self-collection in paired samples from 663 individuals. We found that both nasopharyngeal swab and saliva collection are efficient for the diagnosis of Omicron (including sub-lineages) and for Influenza A, with high sensitivity and accuracy (>90%). The kappa index is 0.938 for Influenza A and 0.905 for SARS-CoV-2. These results showed excellent agreement between the two samples reinforcing saliva samples as a reliable source for detecting Omicron and highlighting saliva as a valid sample source for Influenza detection, considering this cheaper and more comfortable alternative.Keywords
Funding Information
- PROPLAN, Federal University of Parana (Curitiba, Paraná, Brazil) (0494/20)
- Ministry of Science, Technology and Innovation—Brazil—Institutional Network Project (0494/20)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)/PROAP (0494/20)
This publication has 42 references indexed in Scilit:
- Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 DiagnosisEmerging Infectious Diseases, 2020
- New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test?Journal of the Chinese Medical Association, 2020
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysisBMJ, 2020
- Influenza A Virus Cell Entry, Replication, Virion Assembly and MovementFrontiers in Immunology, 2018
- InfluenzaNature Reviews Disease Primers, 2018
- The use of saliva specimens for detection of influenza A and B viruses by rapid influenza diagnostic testsJournal of Virological Methods, 2017
- Comparison between Saliva and Nasopharyngeal Swab Specimens for Detection of Respiratory Viruses by Multiplex Reverse Transcription-PCRJournal of Clinical Microbiology, 2017
- Evaluation of saliva as diagnostic materials for influenza virus infection by PCR-based assaysClinica Chimica Acta, 2016
- Salivary Detection of H1N1 Virus: A Clinical Feasibility InvestigationJournal of Dental Research, 2011
- Characterization of RNA in SalivaClinical Chemistry, 2006